Compare IMMX & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMMX | GAU |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 716.2M | 606.0M |
| IPO Year | 2021 | 2006 |
| Metric | IMMX | GAU |
|---|---|---|
| Price | $8.52 | $1.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $19.20 | $4.08 |
| AVG Volume (30 Days) | 2.1M | ★ 2.9M |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $82.77 |
| Revenue Next Year | N/A | $29.09 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.94 | $1.26 |
| 52 Week High | $12.14 | $3.62 |
| Indicator | IMMX | GAU |
|---|---|---|
| Relative Strength Index (RSI) | 39.80 | 45.86 |
| Support Level | $7.99 | $1.71 |
| Resistance Level | $9.37 | $2.75 |
| Average True Range (ATR) | 0.90 | 0.08 |
| MACD | -0.28 | 0.02 |
| Stochastic Oscillator | 1.93 | 54.55 |
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.